Granules Establishes Prince William County, Virginia, Pharmaceutical Packaging Complex
12/02/2022
The new facility will be part of the company’s Consumer Health division and will return previously outsourced services in-house. Granules will lease 79,000-square-feet of the Parkway 66 property at 7413 Cushing Road in Manassas and build out packaging lines and clean rooms to package and ship pharmaceuticals.
“The addition of a U.S. packaging facility will result in Granules being among the few pharmaceutical companies to be vertically integrated from API to packaging, which will bolster the robustness of Granules’ supply chain while also enabling the company to react even faster to consumers’ growing needs for pharmaceutical products,” said Dr. Krishna Prasad Chigurupati, Founder and Managing Director. “The company chose Virginia because of Prince William County’s responsiveness which allowed Granules faster access to commercialization. In addition, Prince William offers a dynamic and diverse workforce that is eager to work along with the site’s proximity to several major seaports. Granules also chose to expand within Virginia to leverage its existing manufacturing footprint and workforce.”
The Virginia Economic Development Partnership (VEDP) worked with Prince William County to secure the investment. The Governor’s office approved a $200,000 grant from the Commonwealth’s Opportunity Fund to assist Prince William County with the project.
“When a global company like Granules India establishes a second Virginia operation, it reinforces that our business-friendly climate, collaborative environment, and skilled workforce,” noted Secretary of Commerce and Trade Caren Merrick. “The Commonwealth’s pharmaceutical sector has gained significant momentum in recent years, and we thank Granules for continuing our success in this booming industry.”
Founded in 1984 and headquartered in Hyderabad, India, Granules India serves leading brand and generics companies in over 75 countries with eight manufacturing facilities around the world. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages, and its products include common consumer drugs such as acetaminophen, ibuprofen and guaifenesin (key ingredient in Mucinex). Granules employs 130 at a pharmaceutical R&D and manufacturing facility in Fairfax County.
Project Announcements
AXH Air-Coolers Plans Sapulpa, Oklahoma, Manufacturing Operations
02/14/2025
Pulse Primary Care Plans Livonia, Michigan, Headquarters Operations
02/13/2025
PwrQ Expands Hanover, Maryland, Headquarters-Manufacturing Operations
02/13/2025
Premium Guard Plans Weirton, West Virginia, Distribution Operations
02/10/2025
Lufthansa Technik Expands Tulsa, Oklahoma, Operations
02/10/2025
AGS America Expands Opelika, Alabama, Manufacturing Operations
02/10/2025
Most Read
-
2024's Leading Metro Locations: U.S. Cities on the Rise Amid an Economic Reshuffling
Q4 2024
-
The Workforce Factor: How States Are Competing to Build Tomorrow's Talent
Q4 2024
-
Best Practices in Incentives Procurement
Q4 2024
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Five Strategies to Tackle the Data Center Talent Shortage
Q4 2024
-
Microsoft-Three Mile Island Deal Could Signal Path for Nuclear Power to Strengthen Partnerships with Big Tech
Q4 2024
-
Industries Look for Employees in Nontraditional Spaces Amid Labor Shortage
Q4 2024